UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002841
Receipt number R000003463
Scientific Title Measurement of macular retinal nerve fiber layer thickness using spectral domain optical coherence tomography
Date of disclosure of the study information 2009/12/03
Last modified on 2009/12/03 16:27:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of macular retinal nerve fiber layer thickness using spectral domain optical coherence tomography

Acronym

Measurement of macular retinal nerve fiber layer thickness using SD-OCT

Scientific Title

Measurement of macular retinal nerve fiber layer thickness using spectral domain optical coherence tomography

Scientific Title:Acronym

Measurement of macular retinal nerve fiber layer thickness using SD-OCT

Region

Japan


Condition

Condition

Glaucome

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

change (thinning) of macular retinal nerve fiber thickness in glaucoma patient

Basic objectives2

Others

Basic objectives -Others

change (thinning) of macular retinal nerve fiber thickness in glaucoma patient

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

macular retinal nerve fiber thickness at various stage of glaucoma

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

agreement for this measurement

Key exclusion criteria

complications with other macular diseases

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiya Takamatsu

Organization

Hiroshima University

Division name

Department of Ophthalmology and Visual Science

Zip code


Address

1-2-3, Kasumi, Minami-ku, Hiroshima, JAPAN

TEL

082-257-5247

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Hiroshima University

Division name

Department of Ophthalmology and Visual Science

Zip code


Address

1-2-3, Kasumi, Minami-ku, Hiroshima, JAPAN

TEL


Homepage URL


Email



Sponsor or person

Institute

Hiroshima University
Department of Ophthalmology and Visual Science

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2009 Year 12 Month 03 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

correlation with stage of glaucoma (loss of visual field, visual acuity) and macular retinal nerve fiber thickness
retrospective
sampling for case control


Management information

Registered date

2009 Year 12 Month 03 Day

Last modified on

2009 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003463


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name